Table 4 Comparison of microcirculatory transfer function estimates between controls and patients.
Controls (n = 34) | Patients (n = 28) | T-Test P | |
|---|---|---|---|
CBFV-[O2Hb] | |||
Coherence | |||
-VLF | L, 0.48 ± 0.08 R, 0.48 ± 0.10 | L, 0.47 ± 0.10 R, 0.54 ± 0.13 | ns ns |
-LF | L, 0.51 ± 0.11 R, 0.54 ± 0.13 | L, 0.53 ± 0.12 R, 0.51 ± 0.11 | ns ns |
Gain (%/%) | |||
-VLF | L, 0.46 ± 0.37 R, 0.48 ± 0.35 | L, 0.40 ± 0.29 R, 0.53 ± 0.25 | ns ns |
-LF | L, 0.29 ± 0.18 R, 0.33 ± 0.22 | L, 0.33 ± 0.20 R, 0.40 ± 0.37 | ns ns |
Phase (°) | |||
-VLF | L, 52 ± 37 R, 43 ± 38 | L, 54 ± 29 R, 45 ± 32 | ns ns |
-LF | L, 48 ± 20 R, 51 ± 33 | L, 54 ± 29 R, 45 ± 32 | ns ns |
CBFV-[HHb] | |||
Coherence | |||
-VLF | L, 0.48 ± 0.09 R, 0.48 ± 0.10 | L, 0.49 ± 0.19 R, 0.50 ± 0.13 | ns ns |
-LF | L, 0.47 ± 0.13 R, 0.49 ± 0.10 | L, 0.48 ± 0.08 R, 0.48 ± 0.10 | ns ns |
Gain (%/%) | |||
-VLF | L, 0.21 ± 0.13 R, 0.18 ± 0.12 | L, 0.22 ± 0.27 R, 0.22 ± 0.15 | ns ns |
-LF | L, 0.10 ± 0.09 R, 0.16 ± 0.19 | L, 0.13 ± 0.14 R, 0.14 ± 0.10 | ns ns |
Phase (°) | |||
-VLF | L, 258 ± 44 R, 256 ± 44 | L, 268 ± 49 R, 279 ± 45 | ns ns |
-LF | L, 284 ± 38 R, 259 ± 36 | L, 279 ± 36 R, 280 ± 44 | ns ns |
Mean transit time (°) | |||
CBFV-[O2Hb] – CBFV-[HHb] | |||
-VLF | L, 204 ± 51 R, 214 ± 39 | L, 214 ± 56 R, 242 ± 58 | ns ns |
-LF | L, 242 ± 46 (4.84 ± 0.92) R, 207 ± 51 (4.14 ± 0.11) | L, 223 ± 47 (4.46 ± 0.94 R, 223 ± 54 (4.46 ± 1.08) | ns ns |
